Mesenchymal stem cell-laden anti-inflammatory hydrogel enhances diabetic wound healing
Granulation tissue
Cell therapy
DOI:
10.1038/srep18104
Publication Date:
2015-12-08T10:16:12Z
AUTHORS (13)
ABSTRACT
Abstract The purpose of this study was to permit bone marrow mesenchymal stem cells (BMSCs) reach their full potential in the treatment chronic wounds. A biocompatible multifunctional crosslinker based temperature sensitive hydrogel developed deliver BMSCs, which improve inflammation microenvironments detailed vitro investigation found that is suitable for BMSC encapsulation and can promote secretion TGF-β1 bFGF. In vivo , full-thickness skin defects were made on backs db/db mice mimic diabetic ulcers. It revealed inhibit pro-inflammatory M1 macrophage expression. After association with BMSCs treated wound, significantly greater wound contraction observed + group. Histology immunohistochemistry results confirmed contributed rapid healing wounds by promoting granulation tissue formation, angiogenesis, extracellular matrix secretion, re-epithelialization. These show a laden may be promising therapeutic strategy management
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (142)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....